CONMED Corporation  

(Public, NASDAQ:CNMD)   Watch this stock  
Find more results for ABC Corporations I-V
47.64
+0.03 (0.06%)
Jan 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 46.80 - 47.92
52 week 35.85 - 50.47
Open 47.12
Vol / Avg. 237,857.00/174,663.00
Mkt cap 1.31B
P/E 41.08
Div/yield 0.20/1.68
EPS 1.16
Shares 27.52M
Beta 1.43
Inst. own 94%
Apr 22, 2015
Q1 2015 Conmed Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jan 27, 2015
Q4 2014 Conmed Corp Earnings Call - Webcast
Jan 27, 2015
Q4 2014 Conmed Corp Earnings Release
Jan 14, 2015
Conmed Corp at JPMorgan Healthcare Conference - Webcast
Jan 14, 2015
Preliminary 2014 Conmed Corp Earnings Release
Dec 2, 2014
CONMED at 26th Annual Piper Jaffray Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 5.81% 4.35%
Operating margin 8.76% 7.13%
EBITD margin - 16.55%
Return on average assets 4.12% 2.94%
Return on average equity 7.75% 5.42%
Employees 3,600 -
CDP Score - -

Address

525 FRENCH ROAD
UTICA, NY 13502
United States - Map
+1-315-6243215 (Phone)
+1-315-7970321 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

CONMED Corporation (CONMED) is a medical technology company. The Company is engaged in the development, manufacturing and sale on a global basis of surgical devices and related equipment. The Company's products are used by surgeons and physicians in a range of specialties. The Company�s product lines are categorized into three divisions: Orthopedic surgery, Surgical visualization and General surgery. Orthopedic surgery consists of sports medicine instrumentation, bone and specialty powered surgical instruments and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, a line of cardiac monitoring products as well as electrosurgical generators and related instruments. Surgical visualization consists of 2D and 3D video systems for use in minimally invasive orthopedic and general surgery.

Officers and directors

Mark E. Tryniski Independent Chairman of the Board
Age: 53
Bio & Compensation  - Reuters
Curt R. Hartman President, Chief Executive Officer, Director
Age: 50
Bio & Compensation  - Reuters
Robert D. Shallish Jr. Chief Financial Officer, Executive Vice President - Finance
Age: 65
Bio & Compensation  - Reuters
Daniel S. Jonas Executive Vice President - Legal Affairs, General Counsel
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Luke A. Pomilio Chief Financial Officer, Executive Vice President - Finance
Age: 50
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Heather L. Cohen Executive Vice President - Human Resources, Deputy General Counsel, Secretary
Age: 41
Bio & Compensation  - Reuters
Gregory Renard Jones Executive Vice President - Quality Assurance/Regulatory Affairs
Age: 59
Bio & Compensation  - Reuters
Brian P. Concannon Independent Director
Age: 56
Bio & Compensation  - Reuters
Charles Farkas Independent Director
Bio & Compensation  - Reuters
Jo Ann Golden Independent Director
Age: 66
Bio & Compensation  - Reuters